We characterized the influence of the selective corticotropin-releasing factor 2 (CRF 2 ) receptor agonist, urocortin 2 (Ucn 2), injected intracisternally (ic), on gastric emptying and its mechanism of action compared with ic CRF or urocortin (Ucn 1) in conscious rats. The methylcellulose phenol red solution was gavaged 20 min after peptide injection and gastric emptying measured 20 min later. The ic injection of Ucn 2 (0.1 and 1 µg) and Ucn 1 (1 µg) decreased gastric emptying to 37.8 ± 6.9%, 23.1 ± 8.6% and 21.6 ± 5.9%, respectively, compared with 58.4 ± 3.8% in ic vehicle. At lower doses, Ucn 2 (0.03 µg) and Ucn 1 (0.1 µg) had no effect. The CRF 2 antagonist, astressin 2 -B (3 µg, ic), antagonized ic Ucn 2 (0.1 µg) and CRF (0.3 µg) -induced inhibition of gastric emptying. Vagotomy enhanced ic Ucn 2 (0.1 or 1 µg)-induced inhibition of gastric emptying compared to sham-operated group, while blocking ic CRF (1 µg) action (45.5 ± 8.4% vs. 9.7 ± 9.7%). Sympathetic blockade by bretylium prevented ic and intracerebroventricular Ucn 2-induced delayed gastric emptying, while not influencing intravenous Ucn 2-, ic CRF-and ic Ucn 1-induced inhibition of gastric emptying. Prazosin abolished ic Ucn 2 inhibitory effect, while yohimbine and propranolol did not. None of the pretreatment modified basal gastric emptying. These data indicate that ic Ucn 2 induced a central CRF 2 -mediated inhibition of gastric emptying involving sympathetic α 1 -adrenergic mechanisms independent from the vagus contrasting with the vagal-dependent inhibitory actions of CRF and Ucn 1.
INTRODUCTION
just before use, except yohimbine hydrochloride that was dissolved in 5% DMSO and 95 % distilled water. Phenol red and methylcellulose (both from Sigma) were stored at room temperature and prepared on the day of experiments. Ketamine hydrochloride (Ketaset, Fort Dodge Laboratories, Fort Dodge, IA) and xylazine (Rompun, Mobay Co., Shawnee, KS) were used to anesthetize rats undergoing surgery.
Treatments
Intracisternal injections were performed as previously reported (43) under short isoflurane anesthesia (2-3 min, 5% vapor concentration in oxygen; VSS, Rockmart, GA). The occipital membrane was punctured with a 50 µl Hamilton syringe using stereotaxic equipment.
Presence of cerebrospinal fluid into the Hamilton syringe upon aspiration before injection ensured the right needle tip position into the cisterna magna. The volume of injections was 10 µl for CRF, Ucn 1, and Ucn 2, and 5 µl for astressin 2 
-B.
Intracerebroventricular injections were performed as previously described (30) in rats equipped with a chronic icv cannula. Animals were anesthetized with an intraperitoneal (ip) injection of a mixture of ketamine hydrochloride (75 mg/kg) and xylazine (5 mg/kg). A guide cannula (22 ga, Plastic One Products, Roanoke, VA) was implanted into the right lateral brain ventricle according to the following coordinates (mm from bregma: antero-posterior, -0.8; lateral, -1.5; dorsoventral, -3.5). The guide cannula was maintained in place by dental cement anchored by four stainless steel jewelry screws fixed to the skull. After the surgery, animals were housed individually with direct bedding. Experiments were performed in conscious rats starting 10 days after the icv cannulation. During this time, rats were habituated to the manipulation of the cannula and handled daily for a period of about 5 min. The icv injection was performed in CENTRAL UROCORTIN 2 INHIBITS GASTRIC EMPTYING 7 lightly restrainted rats and a 28 ga injection cannula, 1 mm longer than the guide cannula, was connected to a 50 µl Hamilton syringe by a PE-50 catheter (Intramedic Polyethylene Tubing, Clay Adams, Sparks, MD) filled with distilled water. A small air bubble (1 µl) was drawn at the distal end of the PE-50 catheter to separate the injected solution from the water and for visual inspection of the 10 µl injection which was performed slowly over 30 s. At the end of the experiments, the correct location of the cannula into the lateral ventricle was verified by injecting 10 µl of dye (0.1% toluidine blue). Visualization of dye on the wall of the lateral ventricle indicates correctness of the icv injections.
Intravenous injections (0.1 ml) were performed into the right jugular vein after a skin incision under short (2-5 min) isoflurane anesthesia. Wounds were closed with sterile silk (2.0 metric, Ethicon Inc., Somerwille, NJ). Intraperitoneal (0.3 ml) and subcutaneous (0. 1 ml) injections were done in conscious rats. 
Measurement of Gastric Emptying
Gastric emptying of a non-nutrient viscous meal was determined by the phenol red method as described previously (43) . The non-caloric meal consisted of a viscous suspension of continuously stirred 1.5% methylcellulose (w/v) containing phenol red (50 mg/100 ml) given intragastrically through a stainless steel gavage tube (in 1.5 ml volume) to conscious rats. At 20 min after the administration of the solution, rats were euthanized by CO 2 inhalation. The abdominal cavity was opened, the gastro-esophageal junction and the pylorus were clamped, and the stomach was isolated and rinsed in 0.9% saline. The stomach was placed into 100 ml of 0.1 N NaOH and homogenized (Polytron; Brinkman Instruments, Inc., Westbury, NY). The suspension was allowed to settle for 60 min at room temperature, then 5 ml of supernatant was added to 0.5 ml of 20% trichloroacetic acid (w/v) and centrifuged at 3000 rpm at 4ºC for 20 min.
After the supernatant was mixed with 4 ml of 0.5 N NaOH, the absorbance of the sample was read at 560 nm (Shimazu 260 Spectrophotometer). The absorbance of the phenol red recovered from animals euthanized immediately after gavage of the liquid meal was taken as a standard 0% emptying. The percentage of emptying during the 20-min period was calculated with the following formula: % emptying = (1 -absorbance of test sample/absorbance of standard) × 100.
Experimental Protocols
Effect of ic Ucn 2, Ucn 1 and CRF alone or with CRF 2 receptor antagonist on gastric emptying. Fasted rats were briefly anesthetized with isoflurane and injected ic with saline (10 µl), Ucn 2 (0.03, 0.1 or 1 µg), or Ucn 1 (0.1 or 1 µg). In another set of experiments, fasted rats were injected ic (5 µl) with double-distilled water or astressin 2 -B (1, 3 or 10 µg) just before ic injection of saline (10 µl), Ucn 2 (0.1 µg) or CRF (0.3 µg). At 20 min after ic injection, the phenol red methylcellulose solution was delivered intragastrically, and gastric emptying determined 20 min later. 
Effect of subdiaphragmatic vagotomy on ic injection of Ucn 2-and CRF

Statistical Analysis
All results are expressed as mean ± SEM. One-way analysis of variance (ANOVA) followed by Student-Newman-Keuls multiple comparison test was performed for comparison between groups. P values < 0.05 were considered statistically significant.
RESULTS
Ucn 2 and Ucn 1 injected ic inhibit gastric emptying in conscious rats. Ucn 2, injected ic
at 0.03, 0.1 and 1 µg, dose-dependently inhibits gastric emptying of a viscous non-caloric solution in conscious rats (Fig. 1) . At 0.1 µg, ic Ucn 2 significantly reduced gastric emptying to 37.8 ± 6.9% compared with 58.4 ± 3.8% in the ic saline-treated group, while Ucn 1 had no effect (56.3 ± 0.5%). At 1 µg, both Ucn 2 and Ucn 1 injected ic induced a similar inhibition of gastric transit (23.1 ± 8.6% and 21.6 ± 5.9%, respectively, P < 0.05 compared with ic saline; Fig. 1 ).
Astressin 2 -B injected ic prevents ic Ucn 2-and ic CRF-induced delayed gastric emptying.
Astressin 2 -B, injected at 3 and 10 µg, completely prevented ic Ucn 2-induced inhibition of gastric emptying (51.6 ± 2.8% and 54.3 ± 7.2%, respectively, vs. 36.6 ± 6.2%, P < 0.05), while at 1 µg ic, astressin 2 -B was ineffective (27.9 ± 4.5%; Fig.2 ). Similarly, astressin 2 -B injected ic at 3 µg completely antagonized ic CRF (0.3 µg)-induced inhibition of gastric emptying (52.0 ± 4.6% vs. 18.9 ± 4.8% P < 0.05). Astressin 2 -B (3 µg) injected ic alone did not influence basal gastric emptying of a non-nutrient viscous meal (51.3 ± 6.6%; Fig. 2 ).
Vagotomy blocked ic CRF, but not ic Ucn 2, -induced inhibition of gastric emptying. Ucn
2, injected ic at 0.1 µg, did not significantly delay gastric emptying in sham-vagotomized rats (29.0 ± 9.5% vs. 34.6 ± 3.8%, respectively), while there was a significant reduction in vagotomized rats (15.6 ± 3.2% vs. 33.4 ± 5.9%). At 1 µg, ic Ucn 2 significantly reduced gastric emptying in sham-group (16.9 ± 2.9% vs. 34.6 ± 3.8%), and the inhibitory effect was significantly enhanced in vagotomized (6.3 ± 3.0%) compared to sham (16.9 ± 2.9%) groups (Fig.3) . In sham-vagotomized rats, ic injection of CRF (1 µg) significantly delayed gastric emptying (9.7 ± 9.7%) compared to vehicle (34.6 ± 3.8%). Subdiaphragmatic vagotomy completely prevented ic CRF-induced delayed gastric emptying (45.5 ± 8.4%; Fig. 3 ). 
Bretylium prevents ic and icv Ucn 2-, but not iv Ucn 2-, ic CRF-or ic Ucn 1-induced
inhibition of gastric emptying. Ucn 2, injected ic (0.1 µg) in rats under short anesthesia or icv (1 µg) in lightly restrained conscious rats, significantly delayed gastric emptying (27.1 ± 7.3% and 22.7 ± 5.7%, respectively) compared to groups injected with saline either ic (55.8 ± 6.8%) or icv (67.6 ± 13.5%; Fig. 4 ). The inhibitory effect of both ic and icv Ucn 2 was completely prevented by ip bretylium tosylate (56.1 ± 4.4% and 57.0 ± 8.7%, respectively; Fig. 4 ). In contrast, neither ic CRF (0.3 µg) nor ic Ucn 1 (1 µg) -induced delayed gastric emptying (25.3 ± 4.0% and 19.7 ± 5.7, respectively) was altered by pretreatment with ip bretylium tosylate (18.5 ± 4.9% and 11.9 ± 4.4%, respectively; Fig. 4 ). In addition, iv Ucn 2-induced significant suppression of gastric emptying (9.0 ± 3.2%) was not modified by bretylium tosylate pretreatment (5.0 ± 3.5%; Fig.   4C ). In ic, icv or ip saline treated groups, ip bretylium tosylate did not modify gastric emptying compared to ip vehicle ( Fig. 4A-C) .
Prazosin prevents ic Ucn 2-induced inhibition of gastric emptying, while yohimbine and
propranolol had no effect. Pretreatment with the α 1 -adrenergic receptor blocker, prazosin (1 mg/kg, ip), completely abolished the delayed gastric emptying induced by ic Ucn 2 compared with vehicle pretreated group (56.9 ± 9.3% vs. 29.2 ± 3.0%). In contrast the α 2 -adrenergic receptor blocker, yohimbine (4 mg/kg, sc), and β-adrenergic receptor blocker, propranolol (1 mg/kg, ip), did not modify Ucn 2 (0.1 µg, ic)-induced delayed gastric emptying ( Fig.5 ; Table 1 ).
Prazosin, yohimbine and propranolol injected alone with ic saline did not significantly alter the 20 min basal gastric emptying values ( Fig. 5 ; Table 1 ).
DISCUSSION
The present study demonstrates that the newly characterized CRF 2 selective agonist, Ucn 2 injected ic, inhibits gastric emptying of a viscous non-caloric solution in a dose-dependent manner in conscious fasted rats. Ucn 2 injected ic is more potent than Ucn 1 as shown by the significant inhibition of gastric emptying induced by Ucn 2 at 0.1 µg (24 pmol), while Ucn 1 (0.1 µg, 21 pmol) had no effect under these conditions. However, at 1 µg both Ucn 1 and Ucn 2 exert a similar 60% and 63% reduction of gastric emptying, respectively. These observations expend previous reports showing that Ucn 1, injected ic at 0.3 µg (63 pmol), did not alter gastric emptying of a solid meal, while inducing a dose-related inhibition at ic doses of 0.6 and 1 µg (10). Likewise, CRF injected ic at 0.1 µg (21 pmol) had no effect on gastric emptying of a methylcellulose solution while significantly suppressing gastric emptying when injected ic at 0.3-1 µg in conscious rats (28; 43) (present study). Although gastric emptying was monitored in fasted rats briefly anesthetized with isoflurane for the duration of the puncture of the cisterna magna and ic injection, it is unlikely that the peptide inhibitory action represents an interaction with the anesthesia or other stressful aspects of peptide injection. We observed a similar delay in gastric emptying in response to Ucn 2 injected in conscious fasted rats through a chronically implanted icv cannula (present study) or in fed or fasted conscious rats injected icv with CRF (25; 28).
The selective CRF 2 antagonist, astressin 2 -B (38) injected ic, completely prevented both ic Ucn 2 injected iv significantly suppressed gastric emptying of a liquid non-nutrient meal (present study) and of a solid meal in conscious rats (33). However, the inhibitory action of Ucn 2 injected iv was not altered by bretylium pretreatment under conditions blocking ic or icv Ucn 2-induced delayed gastric emptying. These results established that the systemic inhibitory action of Ucn 2 is mediated through distinct mechanisms from those elicited by central administration.
In addition, these data indicate that ic or icv Ucn 2 did not act by leaking into the periphery but is centrally mediated through stimulation of sympathetic pathways. In this regard, since prazosin after its peripheral injection can penetrate the blood-brain barrier and decrease the sympathetic nerve activity in rats (39), it is possible that prazosin in the present study also acts in the brain to block the sympathetic mediated action of ic Ucn 2. So far, two reports indicate that the activation of brain CRF 2 receptors influences other visceral functions through sympathetic pathways (11; 50). The selective CRF 2 agonist, urocortin 3 (17), increases mean arterial blood pressure, heart rate and plasma epinephrine release in conscious rats consistent with activation of sympathetic outflow (11) . The ic injection of Ucn 2 was also recently shown to decrease hepatic surface perfusion and elevate portal pressure through CRF 2 receptors and sympathetic noradrenergic mechanisms in anesthetized rats (50) . Interestingly, consistent reports indicate that Ucn 2, injected icv at 1 µg, displays satiation-like properties that occurred 3-6 h after peptide injection in conscious rats (20). In our study, the inhibition of gastric emptying induced by icv Ucn 2 at 1 µg was observed within the first hour. Whether gastric fullness associated with altered gastric emptying underlies the delayed inhibition of feeding behavior in response to icv Ucn 2 may need to be considered. Previous observations indicate that gastric distention and the presence of food in the stomach act as satiety signals (36).
The exact brain sites at which ic or icv Ucn 2 induces a centrally mediated sympathetic inhibition of gastric motor function are still to be established. In the medulla oblongata, specific CRF 2 binding sites detected by autoradiography are restricted to the nucleus tractus solitarius (NTS) and area postrema, and mRNA encoding the CRF 2 receptor is also densely expressed in both of these structures (27; 45). In addition, icv injection of hUcn 2 at 1 µg in conscious rats gives rise to Fos expression, indicative of neuronal activation in the NTS, the paraventricular nucleus of the hypothalamus (PVN) and central amygdala, while no Fos induction was observed in the locus coeruleus, dorsal motor nucleus (DMN) or area postrema (20; 37). Based on these neuroanatomical and neurofunctional studies, it is likely that ic and icv Ucn 2 act at these responsive brain sites to influence sympathetic outflow and inhibit gastric motor function (13; b Each value is the mean ± SEM of number of rats. * P < 0.05 compared with vehicle + saline. /kg, ip) 
